Human medicines European public assessment report (EPAR): Modigraf, tacrolimus, Graft Rejection, Date of authorisation: 15/05/2009, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Graft Rejection, Date of authorisation: 23/04/2007, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1033e37 ◽

2019 ◽

Author(s):

Keyword(s):

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Nulojix, belatacept, Graft Rejection,Kidney Transplantation, Date of authorisation: 17/06/2011, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d973c2 ◽

2019 ◽

Author(s):

Keyword(s):

Kidney Transplantation ◽

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Graft Rejection, Date of authorisation: 18/07/2014, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1a59725 ◽

2019 ◽

Author(s):

Keyword(s):

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Rapamune, sirolimus, Graft Rejection,Kidney Transplantation, Date of authorisation: 13/03/2001, Revision: 39, Status: Authorised

Case Medical Research ◽

10.31525/cmr-913584 ◽

2019 ◽

Author(s):

Keyword(s):

Kidney Transplantation ◽

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): CellCept, mycophenolate mofetil, Graft Rejection, Date of authorisation: 14/02/1996, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-2115709 ◽

2019 ◽

Author(s):

Keyword(s):

Mycophenolate Mofetil ◽

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Rapamune, sirolimus, Graft Rejection,Kidney Transplantation, Date of authorisation: 13/03/2001, Revision: 38, Status: Authorised

Case Medical Research ◽

10.31525/cmr-90a0fc ◽

2019 ◽

Author(s):

Keyword(s):

Kidney Transplantation ◽

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Graft Rejection, Date of authorisation: 23/04/2007, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1039ad2 ◽

2019 ◽

Author(s):

Keyword(s):

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Simulect, basiliximab, Graft Rejection,Kidney Transplantation, Date of authorisation: 09/10/1998, Revision: 23, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1e9ffbe ◽

2019 ◽

Author(s):

Keyword(s):

Kidney Transplantation ◽

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Nulojix, belatacept, Graft Rejection,Kidney Transplantation, Date of authorisation: 17/06/2011, Revision: 12, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d91fd5 ◽

2019 ◽

Author(s):

Keyword(s):

Kidney Transplantation ◽

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): CellCept, mycophenolate mofetil, Graft Rejection, Date of authorisation: 14/02/1996, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-208eb29 ◽

2019 ◽

Author(s):

Keyword(s):

Mycophenolate Mofetil ◽

Graft Rejection ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text